drugset / Trial / NCT04050111

The Evaluation of Safety and Effectiveness of Intraarticular Administration of Autologous Stromal-Vascular Fraction of Adipose Tissue Cells for Treatment of Knee Joint Arthrosis

NCT04050111

Phase 2 Unknown 30 enrolled Swiss Medica XXI Century S.A.
NaSingle-groupOpen-labelTreatment

Summary

Stromal vascular fraction of cells (SVF) will be extracted from lipoaspirate by enzymatic digestion. SVF will be administered in a single dose intraarticularly. All patients will receive cell therapy.This is a single arm study with no control.

Timeline

Start
2019-08-21
Primary completion
2021-02-22
Completion
2021-08-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Rexlemestrocel-L Cell therapy Other

Indications